Entyvio 64764-0300

Generic: Vedolizumab

Product NDC

64764-0300

Manufacturer: Takeda Pharmaceuticals America, Inc.
Dosage Form: Injection, Powder, Lyophilized, For Solution
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: May 20, 2014
Listing Expires: December 31, 2027
Application: BLA125476

Need to source Entyvio? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Vedolizumab	300 mg/5mL

Drug Class

Integrin Receptor Antagonist [EPC]Integrin Receptor Antagonist [EPC]Integrin Receptor Antagonists [MoA]

Packaging Options(1)

64764-0300-20

1 VIAL, SINGLE-DOSE in 1 CARTON (64764-300-20) / 5 mL in 1 VIAL, SINGLE-DOSE

View →